Literature DB >> 9662410

A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients.

F Cucca1, J V Goy, Y Kawaguchi, L Esposito, M E Merriman, A J Wilson, H J Cordell, S C Bain, J A Todd.   

Abstract

It is generally assumed that the male:female (M:F) ratio in patients with type 1 (insulin-dependent) diabetes mellitus (IDDM) is 1. A recent survey, however, revealed that high incidence countries (mainly European) have a high M:F ratio and low incidence ones (Asian and African) have a low M:F ratio. We have now analysed the M:F ratio according to genotype at the major locus, the major histocompatibility complex (MHC; IDDM1). There are two main IDDM1 susceptibility haplotypes, HLA-DR3 and -DR4, which are present in 95% of Caucasian cases. We report here that in medium/high incidence Caucasian populations from the United States of America, United Kingdom and Sardinia (1307 cases), the bias in male incidence is largely restricted to the DR3/X category of patients (X not = DR4) with a M:F ratio of 1.7 (P=9.3x10(-7)), compared with a ratio of 1.0 in the DR4/Y category (Y;DR3). This is additional evidence for significant heterogeneity between the aetiology of 'DR4-associated' and 'DR3-associated' diabetes. We analysed linkage of type 1 diabetes to chromosome X, and as expected, most of the linkage to Xp13-p11 was in the DR3/X affected sibpair families (n=97; peak multipoint MLS at DXS1068=3.5, P=2.7x10(-4); single point MLS=4.5, P=2.7x10(-5)). This is evidence for aetiological heterogeneity at the IDDM1/MHC locus and, therefore, in the search for non-MHC loci in type 1 diabetes, conditioning of linkage data by HLA type is advised.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662410     DOI: 10.1038/995

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  27 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Age and sex based genetic locus heterogeneity in type 1 diabetes.

Authors:  A D Paterson; A Petronis
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

3.  Multilocus linkage tests based on affected relative pairs.

Authors:  H J Cordell; G C Wedig; K B Jacobs; R C Elston
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

4.  The impact of transmission-ratio distortion on allele sharing in affected sibling pairs.

Authors:  C M Greenwood; K Morgan
Journal:  Am J Hum Genet       Date:  2000-04-20       Impact factor: 11.025

5.  Transmission-ratio distortion at Xp11.4-p21.1 in type 1 diabetes.

Authors:  P Zavattari; L Esposito; S Nutland; J A Todd; F Cucca
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

6.  A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus.

Authors:  S Bolk; A Pelet; R M Hofstra; M Angrist; R Salomon; D Croaker; C H Buys; S Lyonnet; A Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

7.  Evidence of sex-linked effects on the inheritance of human longevity: a population-based study in the Valserine valley (French Jura), 18-20th centuries.

Authors:  A Cournil; J M Legay; F Schächter
Journal:  Proc Biol Sci       Date:  2000-05-22       Impact factor: 5.349

8.  Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.

Authors:  N J Cox; B Wapelhorst; V A Morrison; L Johnson; L Pinchuk; R S Spielman; J A Todd; P Concannon
Journal:  Am J Hum Genet       Date:  2001-08-15       Impact factor: 11.025

9.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

10.  Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.

Authors:  K Decochez; I Truyen; B van der Auwera; I Weets; E Vandemeulebroucke; I H de Leeuw; B Keymeulen; C Mathieu; R Rottiers; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.